Kaizen Advisory’s Zimmer Biomet ZBH Stock Holding History

Kaizen Advisory's ZBH Position: Q4 2018 in Review

Kaizen Advisory reduced its Zimmer Biomet (ZBH) stake by 15% in Q4 2018, selling an estimated $149K and leaving 7,660 shares worth $772K. The position accounts for 0.54% of the portfolio, ranked #42.

Kaizen Advisory first reported a position in ZBH in Q4 2017 and has held it in 5 quarters since. The position peaked at $1.15M in Q3 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

• Kaizen Advisory held 7,660 shares of Zimmer Biomet worth $772K as of Q4 2018.
• Kaizen Advisory sold 1,327 Zimmer Biomet shares in Q4 2018, an estimated $149K.
• Zimmer Biomet made up 0.54% of Kaizen Advisory's portfolio in Q4 2018, its #42 holding.
• Kaizen Advisory first reported a position in Zimmer Biomet in Q4 2017 and has held it in 5 quarters since.
• Kaizen Advisory's Zimmer Biomet position peaked at $1.15M in Q3 2018.
• 871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.